| Mr Richard R Valdes, FNP | |
|
2920 N 4th St, Flagstaff, AZ 86004-1816 | |
| (928) 213-6100 | |
| (928) 774-4808 |
| Full Name | Mr Richard R Valdes |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 21 Years |
| Location | 2920 N 4th St, Flagstaff, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023051273 | NPI | - | NPPES |
| 926818 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | AP1785 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Altacare, Llc | 3274892153 | 3 |
News Archive
Immune response is a balancing act: Too much can lead to inflammatory or autoimmune disease; too little could lead to a serious infection. Regulatory T cells, or Tregs, are important players in striking this balance, acting as "brakes" on the immune response so it doesn't go overboard.
The Food and Drug Administration in the U.S. has given approval for the drug Remicade for use in children with active Crohn's disease(CD), a chronic and debilitating condition.
A new study by scientists from the U.S and U.K. and published on the preprint server bioRxiv in June 2020 reports that there is no evidence of efficacy for the drug hydroxychloroquine (HCQ) against infection with SARS-CoV-2 in hamsters or macaque models. This finding does not support the current widespread prophylactic and therapeutic use of HCQ in COVID-19.
A report by the Eurasian Harm Reduction Network (EHRN highlights the significant inconsistencies that exist in hepatitis C (HCV) diagnosis and treatment across Europe and beyond. In recognition of World Hepatitis Awareness Day, patient groups around the globe are united in their call for action.
Medical device pioneer Stentys announced today the results on 20 patients participating in the Company's ‘APPOSITION I' clinical study—the world's first to treat patients with acute myocardial infarction (AMI) via a self-expanding stent. These data were disclosed today by the study's principal investigator, Christian Spaulding, M.D., Ph.D., to an audience of cardiologists during a Stentys-hosted satellite meeting at the Transcatheter Cardiovascular Therapeutics ("TCT") 2009 annual scientific meeting.
› Verified 1 days ago
| Entity Name | North Country Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073583472 PECOS PAC ID: 8820981053 Enrollment ID: O20040210001107 |
News Archive
Immune response is a balancing act: Too much can lead to inflammatory or autoimmune disease; too little could lead to a serious infection. Regulatory T cells, or Tregs, are important players in striking this balance, acting as "brakes" on the immune response so it doesn't go overboard.
The Food and Drug Administration in the U.S. has given approval for the drug Remicade for use in children with active Crohn's disease(CD), a chronic and debilitating condition.
A new study by scientists from the U.S and U.K. and published on the preprint server bioRxiv in June 2020 reports that there is no evidence of efficacy for the drug hydroxychloroquine (HCQ) against infection with SARS-CoV-2 in hamsters or macaque models. This finding does not support the current widespread prophylactic and therapeutic use of HCQ in COVID-19.
A report by the Eurasian Harm Reduction Network (EHRN highlights the significant inconsistencies that exist in hepatitis C (HCV) diagnosis and treatment across Europe and beyond. In recognition of World Hepatitis Awareness Day, patient groups around the globe are united in their call for action.
Medical device pioneer Stentys announced today the results on 20 patients participating in the Company's ‘APPOSITION I' clinical study—the world's first to treat patients with acute myocardial infarction (AMI) via a self-expanding stent. These data were disclosed today by the study's principal investigator, Christian Spaulding, M.D., Ph.D., to an audience of cardiologists during a Stentys-hosted satellite meeting at the Transcatheter Cardiovascular Therapeutics ("TCT") 2009 annual scientific meeting.
› Verified 1 days ago
| Entity Name | Nextcare Arizona Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043371826 PECOS PAC ID: 9537161260 Enrollment ID: O20070209000357 |
News Archive
Immune response is a balancing act: Too much can lead to inflammatory or autoimmune disease; too little could lead to a serious infection. Regulatory T cells, or Tregs, are important players in striking this balance, acting as "brakes" on the immune response so it doesn't go overboard.
The Food and Drug Administration in the U.S. has given approval for the drug Remicade for use in children with active Crohn's disease(CD), a chronic and debilitating condition.
A new study by scientists from the U.S and U.K. and published on the preprint server bioRxiv in June 2020 reports that there is no evidence of efficacy for the drug hydroxychloroquine (HCQ) against infection with SARS-CoV-2 in hamsters or macaque models. This finding does not support the current widespread prophylactic and therapeutic use of HCQ in COVID-19.
A report by the Eurasian Harm Reduction Network (EHRN highlights the significant inconsistencies that exist in hepatitis C (HCV) diagnosis and treatment across Europe and beyond. In recognition of World Hepatitis Awareness Day, patient groups around the globe are united in their call for action.
Medical device pioneer Stentys announced today the results on 20 patients participating in the Company's ‘APPOSITION I' clinical study—the world's first to treat patients with acute myocardial infarction (AMI) via a self-expanding stent. These data were disclosed today by the study's principal investigator, Christian Spaulding, M.D., Ph.D., to an audience of cardiologists during a Stentys-hosted satellite meeting at the Transcatheter Cardiovascular Therapeutics ("TCT") 2009 annual scientific meeting.
› Verified 1 days ago
| Entity Name | Altacare, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154849610 PECOS PAC ID: 3274892153 Enrollment ID: O20180123000788 |
News Archive
Immune response is a balancing act: Too much can lead to inflammatory or autoimmune disease; too little could lead to a serious infection. Regulatory T cells, or Tregs, are important players in striking this balance, acting as "brakes" on the immune response so it doesn't go overboard.
The Food and Drug Administration in the U.S. has given approval for the drug Remicade for use in children with active Crohn's disease(CD), a chronic and debilitating condition.
A new study by scientists from the U.S and U.K. and published on the preprint server bioRxiv in June 2020 reports that there is no evidence of efficacy for the drug hydroxychloroquine (HCQ) against infection with SARS-CoV-2 in hamsters or macaque models. This finding does not support the current widespread prophylactic and therapeutic use of HCQ in COVID-19.
A report by the Eurasian Harm Reduction Network (EHRN highlights the significant inconsistencies that exist in hepatitis C (HCV) diagnosis and treatment across Europe and beyond. In recognition of World Hepatitis Awareness Day, patient groups around the globe are united in their call for action.
Medical device pioneer Stentys announced today the results on 20 patients participating in the Company's ‘APPOSITION I' clinical study—the world's first to treat patients with acute myocardial infarction (AMI) via a self-expanding stent. These data were disclosed today by the study's principal investigator, Christian Spaulding, M.D., Ph.D., to an audience of cardiologists during a Stentys-hosted satellite meeting at the Transcatheter Cardiovascular Therapeutics ("TCT") 2009 annual scientific meeting.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Richard R Valdes, FNP 1880 W University Ave, Flagstaff, AZ 86001-7159 Ph: (928) 853-9927 | Mr Richard R Valdes, FNP 2920 N 4th St, Flagstaff, AZ 86004-1816 Ph: (928) 213-6100 |
News Archive
Immune response is a balancing act: Too much can lead to inflammatory or autoimmune disease; too little could lead to a serious infection. Regulatory T cells, or Tregs, are important players in striking this balance, acting as "brakes" on the immune response so it doesn't go overboard.
The Food and Drug Administration in the U.S. has given approval for the drug Remicade for use in children with active Crohn's disease(CD), a chronic and debilitating condition.
A new study by scientists from the U.S and U.K. and published on the preprint server bioRxiv in June 2020 reports that there is no evidence of efficacy for the drug hydroxychloroquine (HCQ) against infection with SARS-CoV-2 in hamsters or macaque models. This finding does not support the current widespread prophylactic and therapeutic use of HCQ in COVID-19.
A report by the Eurasian Harm Reduction Network (EHRN highlights the significant inconsistencies that exist in hepatitis C (HCV) diagnosis and treatment across Europe and beyond. In recognition of World Hepatitis Awareness Day, patient groups around the globe are united in their call for action.
Medical device pioneer Stentys announced today the results on 20 patients participating in the Company's ‘APPOSITION I' clinical study—the world's first to treat patients with acute myocardial infarction (AMI) via a self-expanding stent. These data were disclosed today by the study's principal investigator, Christian Spaulding, M.D., Ph.D., to an audience of cardiologists during a Stentys-hosted satellite meeting at the Transcatheter Cardiovascular Therapeutics ("TCT") 2009 annual scientific meeting.
› Verified 1 days ago
Dr. Sarah Lynn Salce, DNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2000 S Thompson St, Flagstaff, AZ 86001 Phone: 928-226-6400 Fax: 928-226-6401 | |
Wyatt D Woodard, MSN, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 320 N Leroux St, Ste B, Flagstaff, AZ 86001 Phone: 928-779-0361 Fax: 928-779-7143 | |
Ms. Sherry Ann Mace, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 77 W Forest Ave, Suite 301, Flagstaff, AZ 86001 Phone: 928-773-2538 | |
Ms. Julie Marie Polzin, RN, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 107 E Oak Ave, Suite 201, Flagstaff, AZ 86001 Phone: 928-913-8800 Fax: 928-913-8801 | |
Dr. Evenstar Amelia Forbach, DNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7510 W Bridle Trl, Flagstaff, AZ 86001 Phone: 928-600-1731 | |
Ms. Sarah Mcnaughton Preston, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1424 N Evergreen Dr, Flagstaff, AZ 86001 Phone: 928-699-9777 |